0.70 USD
↘ 0.03 (4.67%)AT CLOSE (11:59 AM EDT)
Galmed Pharmaceuticals Ltd.
GLMDNASDAQ • USD
0.70
↗ 0.00 (0.29%)
POST MARKET (AS OF 07:10 PM EDT)
Post Market
AS OF 07:10 PM EDT
0.70
↗ 0.00 (0.29%)
Market: CLOSED
Open?$0.73
High?$0.73
Low?$0.69
Prev. Close?$0.73
Volume?121.7K
Avg. Volume?N/A
VWAP?$0.70
Bid / Ask
Bid?$0.60 × 100
Ask?$0.83 × 100
Spread?$0.24
Midpoint?$0.71
Valuation & Ratios
Market Cap?4.6M
Shares Out?6.6M
Float?6.3M
Float %?95.8%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Galmed Pharmaceuticals Ltd. (GLMD) is currently trading at $0.70. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
Themes
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-29.68Distress
Confidence?33%Very Low
Short InterestLow
Short % of Float?0.91%Low
Short Interest?57.6K
Days to Cover?1.0
Free Float6.3M
Avg Daily Volume186.9K
Settlement Date2026-05-15